Skip to main content
SpringerLink
Log in

Nutraceuticals: Scientific and Legal Definitions around the World

  • Chapter
  • First Online:
Nutraceuticals and Cardiovascular Disease

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 312 Accesses

Abstract

The nutraceuticals market is expanding very rapidly, and consumers are increasingly using nutraceuticals to prevent diseases or improve health conditions. Many nutraceuticals have been proven safe and effective in preclinical and clinical trials, but many marketed products still have unsubstantiated claims. Health authorities around the world have thus tried to enforce regulatory constraints to check that efficacy and safety claims be supported by scientific research and rigorous quality controls. Risk management is the overarching principle of the regulations in Europe, the U.S., Canada, Australia/New Zealand, and Japan, and these countries have enforced strict controls on permissible health claims. World-wide, this initiative has been widely accepted and many other countries have implemented legislations aiming at regulating the introduction of nutraceuticals on the market.

This chapter reviews the constraints that regulate the introduction of nutraceuticals in selected countries world-wide, and briefly discusses issues linked to health claim substantiation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Baker, S. An interview with Dr. Stephen DeFelice. https://www.nutraceuticalsworld.com/contents/view_health-e-insights/2011-10-28/an-interview-with-dr-stephen-defelice. Last accessed: 7 June 2019.

  2. DeFelice SL. The nutraceutical revolution: its impact on food industry R&D. Trends Food Sci Technol. 1995;6:59–61.

    Article  CAS  Google Scholar 

  3. European Commission. Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of the Member States relating to food supplements. https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32002L0046&from=EN. Last accessed: 7 June 2019.

  4. U.S. Food and Drug Administration. Dietary Supplement Health and Education Act of 1994, Public Law 103–417, 103rd Congress. https://ods.od.nih.gov/About/DSHEA_Wording.aspx. Last accessed: 7 June 2019.

  5. European Commission Concerted Action on Functional Food Science in Europe (FUFOSE). Scientific concepts of functional foods in Europe: consensus document. Br J Nutr. 1999;81:s1–s27.

    Article  Google Scholar 

  6. Hardy G. Nutraceuticals and functional foods: introduction and meaning. Nutrition. 2000;16:688–9.

    Article  CAS  Google Scholar 

  7. Roberfroid MB. A European consensus of scientific concepts of functional foods. Nutrition. 2000;16:689–91.

    Article  CAS  Google Scholar 

  8. Prasad, E. Nutraceutical market by type – global opportunity analysis and industry forecast 2014–2022. https://www.alliedmarketresearch.com/nutraceuticals-market. Last accessed: 7 June 2019.

  9. Aronson JK. Defining ‘nutraceuticals’: neither nutritious nor pharmaceutical. Br J Clin Pharmacol. 2017 Jan;83:8–19.

    Article  Google Scholar 

  10. Ashor AW, Siervo M, Lara J, Oggioni C, Afshar S, Mathers JC. Effect of vitamin C and vitamin E supplementation on endothelial function: a systematic review and meta-analysis of randomised controlled trials. Br J Nutr. 2015 Apr 28;113:1182–94.

    Article  CAS  Google Scholar 

  11. Ashor AW, Brown R, Keenan PD, Willis ND, Siervo M, Mathers JC. Limited evidence for a beneficial effect of vitamin C supplementation on biomarkers of cardiovascular diseases: an umbrella review of systematic reviews and meta-analyses. Nutr Res. 2019;01(61):1–12.

    Article  Google Scholar 

  12. Autier P, Mullie P, Macacu A, et al. Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials. Lancet Diabetes Endocrinol. 2017;5(12):986–1004.

    Article  CAS  Google Scholar 

  13. Bajnok L. Vitamin D and calcium in the mirror of clinical evidence. Orv Hetil. 2016 Jul;157:1242–7.

    Article  Google Scholar 

  14. Angelo G, Drake VJ, Frei B. Efficacy of multivitamin/mineral supplementation to reduce chronic disease risk: a critical review of the evidence from observational studies and randomized controlled trials. Crit Rev Food Sci Nutr. 2015;55:1968–91.

    Article  CAS  Google Scholar 

  15. Takagi H, Umemoto T, Alice A-LIOCEG. Vitamins and abdominal aortic aneurysm. Int Angiol. 2017 Feb;36:21–30.

    PubMed  Google Scholar 

  16. Food and Agriculture Organization. Codex Alimentarius. http://www.fao.org/3/y7867e/y7867e01.htm. Last accessed: 17 June 2019.

  17. U.S. Food and Drug Administration. Dietary supplements guidance documents & regulatory information. https://www.fda.gov/food/guidance-documents-regulatory-information-topic-food-and-dietary-supplements/dietary-supplements-guidance-documents-regulatory-information. Last accessed: 7 June 2019.

  18. Federal Trade Commission. Frequently Asked Questions (FAQ). https://ods.od.nih.gov/Health_Information/ODS_Frequently_Asked_Questions.aspx. Last accessed: 17 June 2019.

  19. U.S. Food and Drug Administration. Dietary supplement labeling guide. https://www.fda.gov/food/dietary-supplements-guidance-documents-regulatory-information/dietary-supplement-labeling-guide. Last accessed: 17 June 2019.

  20. Government of Canada. Natural health products. https://www.canada.ca/en/health-canada/services/drugs-health-products/natural-non-prescription.html. Last accessed: 17 June 2019.

  21. Bagchi D. Nutraceutical and functional food regulations in the United States and around the world: Academic Press; 2014. p. 592.

    Google Scholar 

  22. Coppens P, da Silva MF, Pettman S. European regulations on nutraceuticals, dietary supplements and functional foods: a framework based on safety. Toxicology. 2006 Apr 3;221:59–74.

    Article  CAS  Google Scholar 

  23. European Food Safety Authority. About EFSA. https://www.efsa.europa.eu/en/aboutefsa. Last accessed: 17 June 2019.

  24. European Commission. Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods. https://eur-lex.europa.eu/legal-content/en/ALL/?uri=CELEX%3A32006R1924. Last accessed: 17 June 2019.

  25. European Commission. Regulation (EU) 2015/2283 of the European Parliament and of the Council of 25 November 2015 on novel foods, amending Regulation (EU) No 1169/2011 of the European Parliament and of the Council and repealing Regulation (EC) No 258/97 of the European Parliament and of the Council and Commission Regulation (EC) No 1852/2001 (Text with EEA relevance). https://eur-lex.europa.eu/legal-content/en/TXT/?uri=CELEX:32015R2283. Last accessed: 17 June 2019.

  26. European Commission. Regulation (EC) No 258/97 of the European Parliament and of the Council of 27 January 1997 concerning novel foods and novel food ingredients. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:31997R0258. Last accessed: 17 June 2019.

  27. European Commission. Regulation (EU) No 609/2013 of the European Parliament and of the Council of 12 June 2013 on food intended for infants and young children, food for special medical purposes, and total diet replacement for weight control and repealing Council Directive 92/52/EEC, Commission Directives 96/8/EC, 1999/21/EC, 2006/125/EC and 2006/141/EC, Directive 2009/39/EC of the European Parliament and of the Council and Commission Regulations (EC) No 41/2009 and (EC) No 953/2009 Text with EEA relevance. https://eur-lex.europa.eu/legal-content/en/TXT/?uri=CELEX:32013R0609. Last accessed: 17 June 2019.

  28. European Commission. Directive 2009/39/EC of the European Parliament and of the Council of 6 May 2009 on foodstuffs intended for particular nutritional uses (recast) (Text with EEA relevance). https://eur-lex.europa.eu/legal-content/en/TXT/?uri=CELEX:32009L0039. Last accessed: 17 June 2019.

  29. European Commission. Directive 2004/24/EC of the European Parliament and of the Council of 31 March 2004 amending, as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human use. 2004.

    Google Scholar 

  30. European Commission. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. 2001.

    Google Scholar 

  31. Federal Register of Legislation, Australian Government. Australia New Zealand Food Standards Code – Schedule 4 – Nutrition, health and related claims. https://www.legislation.gov.au/Details/F2017C00711. Last accessed: 7 June 2019.

  32. Department of Health, Australian Government. Complementary medicine interface issues. https://www.tga.gov.au/complementary-medicine-interface-issues. Last accessed: 17 June 2019.

  33. Parliamentary Counsel Office. Natural health and supplementary products bill. http://www.legislation.govt.nz/bill/government/2011/0324/latest/DLM3984610.html. Last accessed: 17 June 2019.

  34. Chiba T, Sato Y, Kobayashi E, Ide K, Yamada H, Umegaki K. Behaviors of consumers, physicians and pharmacists in response to adverse events associated with dietary supplement use. Nutr J. 2017;16:18.

    Article  Google Scholar 

  35. Shimizu M. History and current status of functional food regulations in Japan. Academic Press. 2014:592.

    Google Scholar 

  36. Amagase H. Current marketplace for probiotics: a Japanese perspective. Clin Infect Dis. 2008 Feb 1;46(Suppl 2):S73–5. discussion S144.

    Google Scholar 

  37. Consumer Affairs Agency. Food labelling. https://www.caa.go.jp/en/policy/food_labeling/. Last accessed: 17 June 2019.

  38. Agency BHR. Food. http://portal.anvisa.gov.br/food. Last accessed: 17 June 2019.

  39. Chemical Inspection and Regulation Service. China health food registration and filing. http://www.cirs-reach.com/news-and-articles/health-food-registration-and-filing.html. Last accessed: 18 June 2019.

  40. Chemical Inspection and Regulation Service (CIRS). Interpretation on China health food registration application service guideline. http://www.cirs-reach.com/news-and-articles/requirement-for-china-health-food-registration-dossier.html. Last accessed: 07 June 2019.

  41. Ministry of Health and Family Welfare, Government of India. Food safety and standards (Food or health supplements, nutraceuticals, foods for special dietary uses, foods for special medical purpose, functional foods and novel food) regulations, 2016. https://archive.fssai.gov.in/home/fss-legislation/fss-regulations.html. Last accessed: 18 June 2019.

  42. Malla S, Hobbs JE, Kofi Sogah E. Functional foods and natural health products regulations In Canada and around the world: a summary. 2013. p. 132.

    Google Scholar 

  43. European Commission. Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods. https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:32006R1924&from=en. Last accessed: 18 June 2019.

  44. Agarwal S, Hordvik S, Morar S. Nutrition and health-related labeling claims for functional foods and dietary supplements in the United States. In: Bagchi D, editor. Nutraceutical and functional food regulations in the United States and around the world: Academic Press; 2014. p. 592.

    Google Scholar 

  45. Hasler CM. Health claims in the United States: an aid to the public or a source of confusion. J Nutr. 2008 Jun;138:1216S–20S.

    Article  CAS  Google Scholar 

  46. European Food Safety Authority. General scientific guidance for stakeholders on health claim applications. EFSA J. 14:4367.

    Google Scholar 

  47. Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490–2004.

    Article  Google Scholar 

  48. Agency for Health Care Policy and Research. Acute pain management: operative or medical procedures and trauma. Rockville, MD: 1993:107.

    Google Scholar 

  49. European Commission. EU Register of nutrition and health claims made on foods. http://ec.europa.eu/food/safety/labelling_nutrition/claims/register/public/?event=register.home&CFID=15635509&CFTOKEN=e8ea0c8bfacf40b4-CAA913C9-DE97-0553-CBBB436489A15B60. Last accessed: 17 June 2019.

  50. Petrini O, Prasad C, Cicero AFG. Clinical studies with botanicals and how to carry them out: the European Union perspective. Curr Top Nutraceutical Res. 2017;15:57–62.

    Google Scholar 

  51. Cicero AFG, Petrini O, Prasad C. Clinical studies with nutraceuticals and how to carry them out. Curr Top Nutraceutical Res. 2017;15:63–6.

    Google Scholar 

  52. Prasad C, Cicero AFG, Petrini O. Planning meaningful clinical trials with botanicals and nutraceuticals: need for a cross-talk between science, business and the regulatory demand. Curr Top Nutraceutical Res. 2017;15:49–56.

    Google Scholar 

  53. HMPC. Guideline on the assessment of clinical safety and efficacy in the preparation of community herbal monographs for well-established and of community herbal monographs/entries to the community list for traditional herbal medicinal products/substances/preparations. EMEA/HMPC/104613/2005. 7 September 2006.

    Google Scholar 

  54. Borghi C, Cicero AF. Nutraceuticals with a clinically detectable blood pressure-lowering effect: a review of available randomized clinical trials and their meta-analyses. Br J Clin Pharmacol. 2017 Jan;83:163–71.

    Article  CAS  Google Scholar 

  55. Cicero AF, Ferroni A, Ertek S. Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects. Expert Opin Drug Saf. 2012;11:753–66.

    Article  CAS  Google Scholar 

  56. Chiesa G, Busnelli M, Manzini S, Parolini C. Nutraceuticals and bioactive components from fish for dyslipidemia and cardiovascular risk reduction. Mar Drugs. 2016 Jun; 08:14.

    Google Scholar 

  57. Cicero AF, Colletti A. Nutraceuticals and blood pressure control: results from clinical trials and meta-analyses. High Blood Press Cardiovasc Prev. 2015 Sep;22:203–13.

    Article  CAS  Google Scholar 

  58. Cicero AF, Colletti A. Combinations of phytomedicines with different lipid lowering activity for dyslipidemia management: the available clinical data. Phytomedicine. 2016 Oct 15;23:1113–8.

    Article  CAS  Google Scholar 

  59. Micucci M, Malaguti M, Toschi TG, et al. Cardiac and vascular synergic protective effect of Olea europea L. leaves and Hibiscus sabdariffa L. flower extracts. Oxidative Med Cell Longev. 2015;2015:318125.

    Article  Google Scholar 

  60. Sanidas E, Grassos C. The role of nutraceuticals in the treatment of primary dyslipidemia. [letter]. Hell J Cardiol. 2018 Aug 07;

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. POLE Pharma Consulting, Breganzona, Switzerland

    Orlando Petrini

  2. Laboratory of Applied Microbiology, Department of Environment, Constructions and Design, University of Applied Sciences of Southern Switzerland – SUPSI, Bellinzona, Switzerland

    Orlando Petrini

Authors
  1. Orlando Petrini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Orlando Petrini .

Editor information

Editors and Affiliations

  1. S. Orsola-Malpighi University Hospital, University of Bologna, BOLOGNA, Bologna, Italy

    Arrigo F.G. Cicero

  2. School of Medicine, University of Palermo, Palermo, Palermo, Italy

    Manfredi Rizzo

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Petrini, O. (2021). Nutraceuticals: Scientific and Legal Definitions around the World. In: Cicero, A.F., Rizzo, M. (eds) Nutraceuticals and Cardiovascular Disease. Contemporary Cardiology. Humana, Cham. https://doi.org/10.1007/978-3-030-62632-7_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-62632-7_3

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-030-62631-0

  • Online ISBN: 978-3-030-62632-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation